bmess Posted - 14 hours ago

$PDSB can’t buy any Christmas gifts because frank took all my money

EddieH2020 Posted - 15 hours ago

$PDSB Bulls got taken to the slaughter

ScottyDoesntKnowMeSon Posted - 15 hours ago

$PDSB data is great, multiple late stage assets, trading at 25 million over cash. Frank just has to come through with partnership. IMO dilution will only prolong the upswing- would be a few months post dilution before it would start to move up again

wyoming2020 Posted - 18 hours ago

$PDSB $MRK could now buy back a bigger, much more further along pipeline for less than what they sold for 3 years ago. Thats smart business. If no partner soon, could be a blinking amber light that there is a more advanced peer lurking in the dark

SaTwits Posted - 21 hours ago

$PDSB rip

Stockman824 Posted - 22 hours ago

$PDSB so very important to read the DD of these 2 very knowledgeable PDSB investors. They contribute a great deal to both Stocktwits and X. Like I’ve said MANY times the data is EXCEPTIONAL but it’s time for management to step up and start delivering on an over year long promise. Arena Pharmaceuticals use to over do it and do an offering and dilute with any good news to the point where they eventually had to do a RS. We are not in that situation but we need $$$ and Frank needs to step up. Arena wound up being a success because the drugs they had were extremely good. Our drugs here are even better and much more important Thank you to @dvice2 and @DesertDweller93 for what they add to the boards https://x.com/desertdweller93/status/1858243248294379618?s=46&t=6YXZ4mtuJUFbALPg2zP-ew

EddieH2020 Posted - 1 day ago

$PDSB Should have waited for $1.70 but your call

rwol9999 Posted - 1 day ago

$PDSB Up on nice volume today!

wyoming2020 Posted - 1 day ago

$PDSB added a tiny bit at 2 because why not at this point

rational1 Posted - 1 day ago

$PDSB

EddieH2020 Posted - 1 day ago

$SLS Glad to be green here unlike these two duds —-> $CLRB $PDSB

Daddybeaks Posted - 1 day ago

$PDSB

Bionoobbb Posted - 1 day ago

$PDSB was that the bottom?

Llamalamb2921 Posted - 1 day ago

$PDSB I’m waiting to see the short interest from 11/15 after a high volume down days. It was 4,470,000 before the recent earnings report. I’m hoping it’s down.

rational1 Posted - 1 day ago

$PDSB

rwol9999 Posted - 1 day ago

$PDSB way ov er sold again... $fhlc same way..

Bionoobbb Posted - 1 day ago

$PDSB added, will add way more if it hits 1.7

dvice2 Posted - 2 days ago

$PDSB great article - set backs aside, medical experts are very bullish on the data https://www.onclive.com/view/versamune-hpv-could-bolster-long-term-efficacy-with-pembrolizumab-in-hpv16-driven-hnscc

The__Shane Posted - 2 days ago

$PDSB Wouldn't you think that the FDA, you know the ones that put this on the fast track would end up having to approve of where & when all the testing was being done along with the Dr's? I think that would have been their next excuse to drag this shit out. I hope I'm wrong but that's how I see it. Their games just might be over. I don't feel sorry for myself but I do feel sorry for my step dad that this might have helped. It was a long time ago...

EddieH2020 Posted - 2 days ago

$PDSB Average down point for us bulls should be $1.70 then $1.40. Pick your poison. My average is $6.82 but will try for $1.70 and say screw it.

DesertDweller93 Posted - 3 days ago

My $PDSB thread over on X for anyone who is interested. https://x.com/DesertDweller93/status/1858243248294379618

Daddybeaks Posted - 4 days ago

@Baltic_Roots most likely 100-120 million and Frank has not even secured a supply of keytruda yet $PDSB

Baltic_Roots Posted - 4 days ago

$PDSB time frame for PH3 : The trial is expected to commence in Q1 2025 , with an estimated completion window of 2–3 years. The Fast Track designation granted by the FDA may allow expedited regulatory processes, potentially shortening this timeline.

Baltic_Roots Posted - 4 days ago

$PDSB okay, f you look at cost of PH this what info can be found : Per-Patient Costs: Average costs range between $36,000 to $50,000 per patient for oncology trials due to specialized monitoring, imaging, and biomarker testing. For 350 patients, this translates to $12.6 million to $17.5 million. Additional Costs: Site Costs: Hiring, training, and maintaining clinical trial sites. Drug Manufacturing: Ensuring sufficient supply of the investigational drug. Regulatory & Administrative Costs: Monitoring, compliance, and reporting. Contingency: Accounting for delays, dropouts, and unforeseen expenses. Considering all these, the total cost might rise to $20 million to $30 million.

HurricanePablo Posted - 4 days ago

$PDSB only a matter of time before this gets delisted. What a scam company

EddieH2020 Posted - 5 days ago

$PDSB Hopefully the Frank boot lickers issue us all apologies over the weekend. I took names of all of them.

AngryTwitts Posted - 5 days ago

@Baltic_Roots @mikeywo are you paper trading $PDSB?

mikeywo Posted - 5 days ago

$PDSB on this Fire Frank Friday I’d like to congratulate Dr Bedo Ado for hitting his goal of a 60% decline YTD of his stock price. This matches the loss from 2022 and 2023. Yet the boot lickers still believe this horrible , lying , crooked CEO should still be running this company. I’m sure they have an excuse for this delay jus t like last years phantom partner and now this years phantom KOL and the mystery 50 oncologists. This trial will not start in Q1 2025 or maybe ever. Can’t wait to see what lying Frank comes up with for the next delay at the next earnings call which isn’t until March. He’s very creative.

Channelchek Posted - 5 days ago

Noble Capital Markets Research Report: PDS Biotechnology ($PDSB) – 3Q24 Reported With Phase 3 VERSATILE-003 Trial Expected To Begin In 1Q25 Progress Toward Phase 3 With New Phase 2 VERSATILE-002 Data. PDS Biotech Reported 3Q24 loss of $10.7 million or $(0.29) per share, a slightly lower loss than we estimated. Earlier this week, modifications to the IND protocol for the Phase 3 VERSATILE-003 trial were submitted to the FDA. Approval is expected by mid-December, which would allow the trial to begin in early 2025. https://www.channelchek.com/news-channel/pds-biotechnology-pdsb-3q24-reported-with-phase-3-versatile-003-trial-expected-to-begin-in-1q25 #Investing #EquityResearch #Biotech #Immunotherapy #Cancer

Baltic_Roots Posted - 5 days ago

$PDSB I have a paper trade account where are all pharma sector companies... PDSB You are Not Alone 🤣🤣🤣